Hallie Kuhn
Angel Investor @ Alexandria Venture Investments
Pasadena, United States
Hallie Kuhn is a Series A investor at Alexandria Venture Investments in Pasadena focused on Life Science and Biotechnology. Hallie Kuhn, Ph.D. is Vice President, Science & Technology, at Alexandria Real Estate Equities, Inc. and its corporate venture arm, Alexandria Venture Investments. In her role, Dr. Kuhn oversees strategic venture investments across Southern California, with a portfolio of over 25 life science investments. She also works closely withAlexandria’s real estate development team to support business development and tenant underwriting in San Diego and Greater LA.
- Total investments:
- 1
- Last investment:
- Lead investor:
- 100%
Last updated:
For AI agents: llms.txt
Industries Hallie Kuhn invests in
Stages Hallie Kuhn invests in
Countries Hallie Kuhn invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Life Science 1 (100%)
- Biotechnology 1 (100%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Eclipse Bioinnovations is a leading RNA genomics company founded in 2017 based on technology developed at the University of California, San Diego. Eclipse's mission is to use their pioneering RNA genomics platform technologies to advance RNA medicines and scientific discovery. Eclipse’s founders developed eCLIP, the world’s most efficient andunique CLIP-seq technology for identifying RNA binding protein gene partners and gene maps. Eclipse’s suite of RNA genomics technologies now cover eCLIP-RBP for mapping the RNA binding proteins, miR-eCLIP for the miR-interactome, m6A-eCLIP for RNA modifications, End-Seq for 5' and 3' mapping, and FLI-Seq for simplifying Crispr library prep. Products are offered as services and kit for biopharma companies and academic researchers, and can be customized for clients. | $14M / Series A / Mar 15, 2022 |
Co-Investors
Alexandria Venture Investments is a venture capital firm that develops work in real estate technology, and healthcare sectors. The company's strategic venture capital platform is Alexandria Venture Investments. Since its inception in 1996, the company has invested in disruptive life science, agrifood tech, and technology companies that aredeveloping transformative new modalities and platforms to meaningfully improve human health.
Alexandria Venture Investments Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Daniel J. Ryan
Co-Chief Investment Officer & Regional Market Director –San Diego
|
|||
Dean A. Shigenaga
Co-President & Chief Financial Officer
|
|||
Joel Marcus
Executive Chairman & Founder
|
|||
Peter M. Moglia
Co-Chief Executive Officer
|
|||
Stephen A. Richardson
Co-Chief Executive Officer
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Hallie Kuhn invest in?
Hallie Kuhn invests primarily in Life Science and Biotechnology startups, most often at Series A stage. Most of the 1 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Hallie Kuhn?
Public channels for Hallie Kuhn include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Hallie Kuhn last invest?
The most recent investment recorded for Hallie Kuhn closed in Mar 2022. Shizune tracks 1 investment in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
